Article
Altered heparan sulfate in ageing and dementia : a potential axis for the dysregulation of BACE-1 in Alzheimer's disease
2017-01-01
Abstract excerpt
Alzheimer’s disease (AD) is characterised by amyloid plaques composed of amyloid-beta (Aβ), the cleavage product of the amyloid precursor protein (APP) by the protease beta-secretase (BACE- 1). Heparan sulfate (HS) inhibits BACE-1 and holds potential as a new drug discovery target; in vivo HS may act as a brake on the generation of Aß via regulation of BACE-1. Previous work has identified the sulfate moieties in H...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1554303b-cc85-52f8-9088-063fd1b51b59
- DOI
- 10.17638/03006939
